FDA flags nationwide duloxetine recall involving nearly 375,000 bottles
Summary:
Researchers use artificial intelligence to rapidly design potent antibodies that can both block and activate G protein-coupled receptors, revolutionizing drug developmentNearly 375,000 bottles of the antidepressant duloxetine have been recalled nationwide after testing found elevated levels of a potentially cancer-causing impurity, according to the U.S. Food and Drug Administration.
Brexit tore apart European science — now the research rifts are healing
Summary:
Ten years after the United Kingdom voted to leave the European Union, there are signs that their relationship in research is healing
Biogen makes up to $1B deal for secretive anti-inflammatory biotech
Summary:
Biogen will pay as much as $1 billion — “predominantly” in milestone payments — to acquire a San Diego biotech that has disclosed little about its pipeline.
cAMPfield lands $180M to build gut disease drug
Summary:
The biotech is advancing an anti-inflammatory drug that originated with vTv for inflammatory bowel diseases, leaning on a better side effect profile.
Can AI do scientific research? Billions are pouring in to find out
Summary:
Takes a deep dive into why billions are flowing into a new vintage of startups with wildly ambitious aims of remaking the scientific method and putting AI at the heart of the modern laboratory
